A fatal case of acute myocardial infarction following the improvement of influenza a(H1N1)pdm2009-related acute myocarditis

Internal Medicine

Volumn 53, Issue 18, 2014, Pages 2153-2157

  Iwanaga, Naoki ^a,b   Nakamura, Shigeki ^a   Fukuda, Yuichi ^b   Takazono, Takahiro ^a   Imamura, Yoshifumi ^a   Izumikawa, Koichi ^a   Yanagihara, Katsunori ^c   Soda, Hiroshi ^b   Tashiro, Takayoshi ^d   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sasebo Shiritsu Sogo Hospital   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Acute myocarditis; C reactive protein; Excessive inflammatory cytokines; Influenza A(H1N1)pdm2009; Myocardial infarction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR ALPHA; C REACTIVE PROTEIN; CREATINE KINASE; DIURETIC AGENT; DOBUTAMINE; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PROCALCITONIN; SIALIDASE INHIBITOR; TROPONIN T; VIRUS DNA;

2009 H1N1 INFLUENZA; ACUTE HEART INFARCTION; ADULT; ARTICLE; AUSCULTATION; AUTOPSY; CARDIOMEGALY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DIABETIC NEPHROPATHY; DYSPNEA; ELECTROCARDIOGRAPHY; EPIGASTRIC PAIN; FEVER; FLU LIKE SYNDROME; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN TISSUE; HYPOKINESIA; HYPOXIA; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MALE; MEDICAL PROCEDURES; MIDDLE AGED; MYOCARDITIS; PERCUTANEOUS CARDIOPULMONARY SUPPORT; PLEURA EFFUSION; POSITIVE END EXPIRATORY PRESSURE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINUS TACHYCARDIA; ST SEGMENT ELEVATION; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; COMPLICATION; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; FATALITY; GENETICS; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; MYOCARDIAL INFARCTION; VIROLOGY;

DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATAL OUTCOME; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84907465799     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.2435     Document Type: Article

References (21)

1. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 45: 169-173, 2009.
2. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362: 1708-1719, 2010.
3. Kodama M. Influenza myocarditis. Circ J 74: 2060-2061, 2010.
4. Kamigaki T, Oshitani H. Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan. PLoS Curr Influenza 20: RRN1139, 2009.
5. Ukimura A, Izumi T, Matsumori A. Clinical Research Committee on Myocarditis Associated with the 2009 Influenza A (H1N1) Pandemic in Japan organized by the Japanese Circulation Society. Circ J 74: 2193-2199, 2010.
6. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351: 2611-2618, 2004.
7. Guan XR, Li X, Xin XM, et al. Influenza virus infection and risk of acute myocardial infarction. Inflammation 31: 266-272, 2008.
8. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 9: 601-610, 2009.
9. Khater F, Moorman JP. Complications of influenza. South Med J 96: 740-743, 2003.
10. Martin SS, Hollingsworth CL, Norfolk SG, Wolfe CR, Hollingsworth JW. Reversible cardiac dysfunction associated with pandemic 2009 influenza A(H1N1). Chest 137: 1195-1197, 2010.
11. Mamas MA, Fraser D, Neyses L. Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 130: 304-309, 2008.
12. Blum A, Sclarovsky S, Rechavia E. “Infective” myocardial infarction. Chest 103: 1084-1086, 1993.
13. Marsden PA. Inflammation and coagulation in the cardiovascular system: the contribution of influenza. Circ Res 99: 1152-1153, 2006.
14. Guan X, Yang W, Sun X, et al. Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction. Inflamm Res 61: 591-598, 2012.
15. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 52: 1527-1539, 2008.
16. Kohno S, Kida H, Mizuguchi M, Shimada J. Efficacy and safety of intravenous peramivir for the treatment of seasonal influenza virus infection. Antimicrob Agents Chemother 54: 4568-4574, 2010.
17. Hernandez JE, Adiga R, Armstrong R, et al.: on behalf of the eIND Peramivir Investigators. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an emergency IND program in the United States. Clin Infec Dis 52: 695-706, 2011.
18. Nasu T, Ogawa D, Wada J, Makino H. Peramivir for severe influenza infection in a patient with diabetic nephropathy. Am J Respir Crit Care Med 182: 1209-1210, 2010.
19. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009). Circ J 75: 734-743, 2011.
20. Kodama M, Okura Y, Hirono S, et al. A new scoring system to predict the efficacy of steroid therapy for patients with active myocarditis: a retrospective study. Jpn Circ J 62: 715-720, 1998.
21. Kato S, Morimoto S, Hiramitsu S, et al. Successful high-dose intravenous immunoglobulin therapy for a patient with fulminant myocarditis. Heart Vessels 22: 48-51, 2007.